Earnings History Data for Pear Therapeutics, Inc. (PEAR) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Pear Therapeutics, Inc.

Pear Therapeutics Inc. is involved in developing and commercializing software-based medicines, called prescription digital therapeutics. The company's principal pipeline of products include reset(R), for the treatment of substance use disorder, reSET-O(R), for the treatment of opioid use disorder and Somryst(R) for the treatment of chronic insomnia. Pear Therapeutics Inc., formerly known as Thimble Point Acquisition Corp., is based in BOSTON.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
14-11-2022	AH	4:00 PM ET (Nov 14)	PEAR	Pear Therapeutics, Inc.	403.82	-0.22	-0.21	0.00	Pear Therapeutics GAAP EPS of -$0.22 in-line, revenue of $4.1M misses by $0.24M [11/14/2022 4:27 PM]	2.50	-0.02 (-0.99%)	2.52	0.0 (0.00%)	1.34 - 14.60	253,753	210,000	3,174
Pear Therapeutics GAAP EPS of -$0.22 in-line, revenue of $4.1M misses by $0.24M [11/14/2022 4:27 PM] Pear Therapeutics Reports Third Quarter 2022 Results [Nov-14-22 04:02PM]
11-08-2022	AH	4:00 PM ET (Aug 11)	PEAR	Pear Therapeutics, Inc.	196.10	-0.22	-0.25	0.00	Pear Therapeutics GAAP EPS of $0.04 beats by $0.29, revenue of $3.3M misses by $0.94M [8/11/2022 4:48 PM]	2.00	-0.28 (-12.11%)	2.21	-0.06 (-2.64%)	1.34 - 14.60	375,443	210,000	3,210
Pear Therapeutics GAAP EPS of $0.04 beats by $0.29, revenue of $3.3M misses by $0.94M [8/11/2022 4:48 PM] Pear Therapeutics Reports Second Quarter 2022 Results [Aug-11-22 04:02PM] Pear Therapeutics Announces Publication of New Analysis of Real-World Data Showing Reduction in Insomnia Severity, Healthcare Resource Utilization and Associated Costs in Adults Using Somryst® [Aug-10-22 04:02PM]
16-05-2022	AH	4:00 PM ET (May 16)	PEAR	Pear Therapeutics, Inc.	496.53	-0.26	-0.23	0.00		4.27	0.68 (18.94%)	3.82	0.23 (6.41%)	2.81 - 14.60	243,930	350,000	312
Pear Therapeutics Reports First Quarter 2022 Financial Results [May-16-22 04:02PM]
28-03-2022	AH	After the close (Mar 28)	PEAR	Pear Therapeutics, Inc.	610.45	-0.24	-0.23	0.00	GAAP EPS of -$0.57 beats by $2.30, revenue of $4.2M misses by $0.21M [3/28/2022 4:04 PM]	4.59	0.35 (8.25%)	4.30	0.06 (1.42%)	3.46 - 14.60	378,540	380,000	5,006
GAAP EPS of -$0.57 beats by $2.30, revenue of $4.2M misses by $0.21M [3/28/2022 4:04 PM] Pear Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results [Mar-28-22 04:02PM]